Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Robot-Assisted surgery showdown for rare bowel condition in kids

NCT ID NCT07343622

First seen Feb 01, 2026 · Last updated Jun 22, 2026 · Updated 16 times

Summary

This study compares two surgical techniques—Duhamel and modified Soave—for treating total colonic Hirschsprung disease, a severe birth defect where nerve cells are missing from the colon. Fifty children who had a first surgery as newborns will be randomly assigned to one of the two procedures. Researchers will track bowel function and rates of a serious complication called enterocolitis over two years to see which method works better.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIRSCHSPRUNG DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Affiliated Hospital of Zunyi Medical University

    Zunyi, Guizhou, 563000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

surgical procedure (Duhamel or Soave pull-through)

What this could lead to

If successful, this study could help doctors choose the better surgical method for children with severe Hirschsprung disease, improving bowel function and reducing complications.

What could go wrong

This is a small, early-stage trial with only 50 participants, and it compares two existing procedures rather than testing a new treatment. Results may not apply to all patients.

Conditions

The condition(s) this trial relates to.

aganglionosis, total intestinal dyschromatosis universalis hereditaria Hirschsprung disease southeast Asian ovalocytosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.